Franco-Austrian firm Valneva wins EU COVID jab deal
Franco-Austrian biotech firm Valneva will supply the European Union with as many as 60 million doses of its COVID-19 vaccine under the terms of a deal announced on Wednesday.
Nov 10, 2021
0
23
Franco-Austrian biotech firm Valneva will supply the European Union with as many as 60 million doses of its COVID-19 vaccine under the terms of a deal announced on Wednesday.
Nov 10, 2021
0
23
Globally affordable COVID-19 vaccines will not be accessible until governments stop allowing vaccine companies to keep their manufacturing costs secret, according to a new paper published by the Journal of the Royal Society ...
Nov 4, 2021
0
1
It's well-known that COVID-19 pandemic restrictions pretty much quashed the 2020-2021 flu season, with influenza cases falling to never-before-seen lows in the United States.
Oct 25, 2021
1
1106
Australian medical tech manufacturer Ellume said it had recalled almost 200,000 at-home COVID-19 tests in the United States over an increased chance of false positives.
Oct 6, 2021
0
9
(HealthDay)—People newly infected with COVID-19 might soon have access to what essentially is Tamiflu for the novel coronavirus, a breakthrough that experts say would drastically alter the course of the ongoing pandemic.
Oct 4, 2021
0
5
A combination of factors including the current corporate tax rate makes pharmaceutical production in the United States more attractive now than investing in either China or India. And adopting advanced technologies such as ...
Sep 30, 2021
0
2
A review by the GLUTEN3S research group at the UPV/EHU-University of the Basque Country describes the nutritional imbalances found in adults suffering from celiac disease who follow a gluten-free diet. The keys to avoiding ...
Sep 27, 2021
0
5
The European Alliance of Associations for Rheumatology, EULAR, wishes to highlight increasing shortages of vital anti-inflammatory drugs used in the treatment of arthritis, vasculitis and other inflammatory RMDs.
Sep 16, 2021
0
25
The monoclonal antibody lanadelumab has been approved in Europe since 2015 as a long-term prophylaxis to prevent attacks of hereditary angioedema. Since this is a rare disease, the Federal Joint Committee (G-BA) initially ...
Aug 20, 2021
0
2
The World Health Organization on Wednesday urged COVID-19 vaccine manufacturers to keep their prices low and affordable, after reports that two producers will raise the cost they are charging the EU.
Aug 4, 2021
0
2